Advertisement
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Advertisement
No AccessJournal of UrologyInvestigative Urology1 Dec 2012

Diagnostic Potential of Urinary α1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer

    View All Author Information

    Purpose:

    The ability to reliably diagnose bladder cancer in voided urine samples would be a major advance. Using high throughput technologies, we identified a panel of bladder cancer associated biomarkers with potential clinical usefulness. In this study we tested 4 potential biomarkers for the noninvasive detection of bladder cancer.

    Materials and Methods:

    We examined voided urine specimens from 124 patients, including 63 newly diagnosed with bladder cancer and 61 controls. Concentrations of proteins were assessed by enzyme-linked immunosorbent assay, including α1-antitrypsin, apolipoprotein E, osteopontin and pentraxin 3. Data were compared to the results of urinary cytology and the BTA Trak® enzyme-linked immunosorbent assay based bladder cancer detection assay. We used the AUC of ROC curves to compare the usefulness of each biomarker to detect bladder cancer.

    Results:

    Urinary levels of α1-antitrypsin, apolipoprotein E and bladder tumor antigen were significantly increased in subjects with bladder cancer. α1-Antitrypsin (AUC 0.9087, 95% CI 0.8555–0.9619) and apolipoprotein E (AUC 0.8987, 95% CI 0.8449–0.9525) were the most accurate biomarkers. The combination of α1-antitrypsin and apolipoprotein E (AUC 0.9399) achieved 91% sensitivity, 89% specificity, and a positive and negative predictive value of 89% and 90%, respectively. Multivariate regression analysis highlighted only apolipoprotein E as an independent predictor of bladder cancer (OR 24.9, 95% CI 4.22–146.7, p = 0.0004).

    Conclusions:

    Alone or in combination, α1-antitrypsin and apolipoprotein E show promise for the noninvasive detection of bladder cancer (OR 24.9, 95% CI 4.22–146.7, p = 0.0004). Larger, prospective studies including more low grade, low stage tumors are needed to confirm these results.

    References

    • 1 : Cancer statistics, 2012. CA Cancer J Clin2012; 62: 10. Google Scholar
    • 2 : Urine cytology of transitional cell neoplasms. Urol Clin North Am1979; 6: 599. Crossref, MedlineGoogle Scholar
    • 3 : Usefulness of the BTA STAT Test for the diagnosis of bladder cancer. Urology2001; 57: 685. Google Scholar
    • 4 : Use of the NMP22 BladderChek test in the diagnosis and follow-up of urothelial cancer: a cross-sectional study. Urology2010; 77: 154. Google Scholar
    • 5 : Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Cancer2007; 111: 517. Google Scholar
    • 6 : Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia. Cancer Epidemiol Biomarkers Prev2009; 18: 444. Google Scholar
    • 7 : Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res2007; 6: 2631. Google Scholar
    • 8 : Urinary glycoprotein biomarker discovery for bladder cancer detection using LC-MS/MS and label-free quantification. Clin Cancer Res2011; 17: 3349. Google Scholar
    • 9 : Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology2005; 66: 35. Google Scholar
    • 10 : Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract2004; 21: 4. Google Scholar
    • 11 : AJCC Cancer Staging Manual. American Joint Committee on Cancer, American Cancer Society New York: Springer-Verlag2002. Google Scholar
    • 12 : The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol2005; 13: 143. Google Scholar
    • 13 : Discovery of urinary biomarkers. Molec Cell Proteom2006; 5: 1760. Google Scholar
    • 14 : Urinary excretion of creatinine in normal subjects. Chin Pharmaceut J1992; 44: 235. Google Scholar
    • 15 : Estimation of the Youden Index and its associated cutoff point. Biom J2005; 47: 458. Google Scholar
    • 16 : Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci U S A2011; 108: 14813. Google Scholar
    • 17 : Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation. J Biol Chem2001; 276: 43455. Google Scholar
    • 18 : Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet2000; 1: 507. Google Scholar
    • 19 : The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression. DNA Cell Biol2011; 30: 851. Google Scholar
    • 20 : An interaction between apolipoprotein E and TERE1 with a possible association with bladder tumor formation. J Cell Biochem2005; 95: 419. Google Scholar
    • 21 : Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. Proteomics2012; 12: 135. Google Scholar
    • 22 : Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab2010; 99: 157. Google Scholar
    • 23 : Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Clin Chim Acta2009; 404: 111. Google Scholar
    • 24 : Protease inhibitor SERPINA1 expression in epithelial ovarian cancer. Clin Exp Metastasis2010; 27: 55. Google Scholar
    • 25 : Spotlight on differentially expressed genes in urinary bladder cancer. PLoS One2011; 6: e18255. Google Scholar
    • 26 : Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. Urol Oncol2011; 29: 703. Google Scholar
    • 27 : Interleukin-1-inducible genes in endothelial cells: Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem1992; 267: 22190. Google Scholar
    • 28 : Pentraxin-3 is a novel biomarker of lung carcinoma. Clin Cancer Res2011; 17: 2395. Google Scholar
    • 29 : Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocr Relat Cancer2011; 18: 465. Google Scholar
    • 30 : Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria. BMC Urol2009; 9: 12. Google Scholar